The protective effect of resveratrol on dimethylnitrosamine-induced liver fibrosis in rats

Archives of Pharmacal Research

Volumn 33, Issue 4, 2010, Pages 601-609

  Hong, Sang Won ^a   Jung, Kyung Hee ^a   Zheng, Hong Mei ^a   Lee, Hee Seung ^a   Suh, Jun Kyu ^a   Park, In Suh ^a   Lee, Don Haeng ^a   Hong, Soon Sun ^a  

^a Inha University School of Medicine   (South Korea)

Author keywords

SMA INTRO; Antioxidant enzyme; Collagen type I; Liver injury; Resveratrol; TGF 1

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA SMOOTH MUSCLE ACTIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; COLLAGEN TYPE 1; DIMETHYLNITROSAMINE; GLUTATHIONE PEROXIDASE; HYDROXYPROLINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MALONALDEHYDE; MESSENGER RNA; NITRIC OXIDE; RESVERATROL; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER PROTECTION; LIVER WEIGHT; MALE; NONHUMAN; RAT; WEIGHT REDUCTION;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; BODY WEIGHT; DIMETHYLNITROSAMINE; LIPID PEROXIDATION; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; STILBENES;

EID: 77954544210     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-010-0415-y     Document Type: Article

References (46)

1. Ajmo, J. M., Liang, X., Rogers, C. Q., Pennock, B., and You,M., Resveratrol alleviates alcoholic fatty liver in mice.Am. J. Physiol. Gastrointest. Liver Physiol., 295, 833-842 (2008).
2. Bennett, R. G., Kharbanda, K. K., and Tuma, D. J., Inhibition of markers of hepatic stellate cell activation by the hormone relaxin. Biochem. Pharmacol., 66, 867-874 (2003).
3. Birrell, M. A., McCluskie, K., Wong, S., Donnelly, L. E.,Barnes, P. J., and Belvisil, M. G., Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NFkappa B-independent mechanism. FASEB J., 19, 840-841 (2005).
4. Bisht, K., Wagner, K. H., and Bulmer, A. C., Curcumin,resveratrol and flavonoids as anti-inflammatory, cytoand DNA-protective dietary compounds. Toxicology, Epub ahead of print (2009).
5. Breitkopf, K., Sawitza, I., and Gressner, A. M., Characterization of intracellular pathways leading to coinduction of hrombospondin-1 and TGF-beta1 expression in rat hepatic stellate cells. Growth Factors, 23, 77-85 (2005).
6. Bujanda, L., Hijona, E., Larzabal, M., Beraza, M., Aldazabal,P., Garcia-Urkia, N., Sarasqueta, C., Cosme, A., Irastorza, B., Gonzalez, A., and Arenas, J. I., Jr., Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol., 8, 35 (2008).
7. Cai, Y. J., Fang, J. G., Ma, L. P., Yang, L., and Liu, Z. L.,Inhibition of free radical-induced peroxidation of rat liver microsomes by resveratrol and its analogues. Biochim.Biophys. Acta, 1637, 313-318 (2003).
8. Caro, A. A. and Cederbaum, A. I., Oxidative stress, toxicology,and pharmacology of CYP2E1. Annu. Rev. Pharmacol.Toxicol., 44, 27-42 (2004).
9. Casini, A., Ceni, E., Salzano, R., Milani, S., Schuppan, D., and Surrenti, C., Acetaldehyde regulates the gene expression of matrix- metalloproteinase-1 and -2 in human fat-storing cells. Life Sci., 55, 1311-1316 (1994).
10. 4 treatment in rats. J. Appl. Toxicol., 28, 35-43 (2008).
11. Chen, A. and Zhang, L., The antioxidant (-)-epigallocatechin-3-gallate inhibits rat hepatic stellate cell proliferation in vitro by blocking the tyrosine phosphorylation and reducing the gene expression of platelet-derived growth factorbeta receptor. J. Biol. Chem., 278, 23381-23389 (2003).
12. Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A.,Ciliberto, G., Furth, E. E., Poli, V., and Taub, R., Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science, 274, 1379-1383 (1996).
13. Donnelly, L. E., Newton, R., Kennedy, G. E., Fenwick, P. S.,Leung, R. H., Ito, K., Russell, R. E., and Barnes, Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am. J. Physiol. Lung Cell Mol. Physiol., 287, L774-L783 (2004).
14. Ezquerro, I. J., Lasarte, J. J., Dotor, J., Castilla-Cortazar, I.,Bustos, M., Penuelas, I., Blanco, G., Rodriguez, C., Lechuga Mdel, C., Greenwel, P., Rojkind, M., Prieto, J., and Borras-Cuesta, F., A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury. Cytokine, 22,12-20 (2003).
15. Friedman, S. L., Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol.Chem., 275, 2247-2250 (2000).
16. George, J., Rao, K. R., Stern, R., and Chandrakasan, G., Dimethylnitrosamine-induced liver injury in rats: the early eposition of collagen. Toxicology, 156, 129-138 (2001).
17. Godichaud, S., Krisa, S., Couronne, B., Dubuisson, L., Merillon,J. M., Desmouliere, A., and Rosenbaum, J., Deactivation of cultured human liver myofibroblasts by trans-resveratrol,a grapevine-derived polyphenol. Hepatology, 31, 922-931 (2000).
18. Hierholzer, C., Harbrecht, B., Menezes, J. M., Kane, J.,Macmicking, J., Nathan, C. F., Peitzman, A. B., Billiar, T.R., and Twardy, D. J., Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J. Exp. Med., 187, 917-928 (1998).
19. Jamall, I. S., Finelli, V. N., and Que Hee, S. S., A simple method to determine nanogram levels of 4-hydroxyproline in ological tissues. Anal. Biochem., 112, 70-75 (1981).
20. Jaeschke, H., Reactive oxygen and mechanisms of inflammatory liver injury., J. Gastroenterol. Hepatol., 15, 718-724 (2000).
21. Kasdallah-Grissa, A., Mornagui, B., Aouani, E., Hammami,M., El May, M., Gharbi, N., Kamoun, A., and El-Fazaa, S.,Resveratrol, a red wine polyphenol, attenuates ethanolinduced oxidative stress in rat liver. Life Sci., 80, 1033-1039 (2007).
22. Kim, K. Y., Rhim, T., Choi, I., and Kim, S. S., N-acetylcysteine induces cell cycle arrest in hepatic stellate cells through its reducing activity. J. Biol. Chem., 276, 40591-40598 (2001).
23. Leonard, S. S., Xia, C., Jiang, B. H., Stinefelt, B., Klandorf,H., Harris, G. K., and Shi, X., Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun., 309,1017-1026 (2003).
24. Lopez-Velez, M., Martinez-Martinez, F., and Del Valle-Ribes, C., The study of phenolic compounds as natural antioxidants in wine. Crit. Rev. Food Sci. Nutr., 43, 233-244 (2003).
25. Ma, Z. H., Ma, Q. Y., Wang, L. C., Sha, H. C., Wu, S. L., and Zhang, M., Effect of resveratrol on peritoneal macrophages in rats with severe acute pancreatitis. Inflamm.Res., 54, 522-527 (2005).
26. Malinski, J. A., Zera, E. M., Angleson, J. K., and Wensel, T.G., High affinity interactions of GTPgammaS with the terotrimeric G protein, transducin. Evidence at high and low protein concentrations. J. Biol. Chem., 271,12919-12924 (1996).
27. Niehaus, W. G., Jr. and Samuelsson, B., Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur. J. Biochem., 6, 126-130 (1968).
28. Nordmann, R., Alcohol and antioxidant systems. Alcohol Alcohol., 29, 513-522 (1994).
29. Novo, E. and Parola, M., Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair, 1, 5 (2008).
30. Ohara, F., Nii, A., Sakiyama, Y., Tsuchiya, M., and Ogawa,S., Pathophysiological characteristics of methylnitrosamine-induced liver fibrosis in acute and chronic injury models: a possible contribution of KLF5 to fibrogenic responses. Dig. Dis. Sci., 53, 2222-2232 (2008).
31. Pinzani, M. and Marra, F., Cytokine receptors and signaling in hepatic stellate cells. Semin. Liver Dis., 21, 397-416 (2001).
32. Ramadori, G. and Armbrust T., Cytokines in the liver. Eur.J. Gastroenterol. Hepatol., 13, 777-784 (2001).
33. Rivera, H., Shibayama, M., Tsutsumi, V., Perez-Alvarez, V.,and Muriel, P., Resveratrol and trimethylated resveratrol protect from acute liver damage induced by CCl4 in the rat. J. Appl. Toxicol., 28, 147-155 (2008).
34. Rushmore, T. H. and Kong, A. N., Pharmacogenomics,regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr. Drug Metab., 3, 481-490 (2002).
35. Shang, J., Chen, L., Xiao, F., Sun, H., Ding, H., and Xiao, H.,Resveratrol improves non-alcoholic fatty liver disease by activating AMP activated protein kinase. Acta Pharmacol.Sin., 29, 698-706 (2008).
36. Seifert, W. F., Bosma, A., Hendriks, H. F., Van Leeuwen, R.E., Van Thiel-de Ruiter, G. C., Seifert-Bock, I., Knook, D.L., and Brouwer, A., Beta-carotene (provitamin A) decreases the severity of CCl4-induced hepatic inflammation and fibrosis in rats. Liver, 15, 1-8 (1995).
37. Shafritz, D. A., Oertel, M., Menthena, A., Nierhoff, D., and Dabeva, M. D., Liver stem cells and prospects for liver reconstitution by transplanted cells. Hepatology, 43, S89-S98 (2006).
38. Shiba, M., Shimizu, I., Yasuda, M., Ii, K., and Ito, S., Expression of type I and type III collagens during the course of dimethylnitrosamine-induced hepatic fibrosis in rats. Liver, 18, 196-204 (1998).
39. Sohara, N., Znoyko, I., Levy, M. T., Trojanowska, M., and Reuben, A., Reversal of activation of human myofibroblast-like cells by culture on a basement membrane-like substrate. J. Hepatol., 37, 214-221 (2002).
40. Tilg, H. and Diehl, A. M., Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med., 343, 1467-1476 (2000).
41. Wallace, J. D. and Levy, L. L., Blood pressure after stroke.JAMA, 246, 2177-2180 (1981).
42. Weber, L. W., Boll, M., and Stampfl, A., Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit. Rev. Toxicol., 33, 105-136 (2003).
43. Wills, P. J., Suresh, V., Arun, M., and Asha, V. V., Antiangiogenic effect of Lygodium flexuosum against nitrosodiethylamine-induced hepatotoxicity in rats.Chem. Biol. Interact., 164, 25-38 (2006).
44. Wolter, F., Ulrich, S., and Stein, J., Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in colorectal cancer: key role of polyamines? J.Nutr., 134, 3219-3222 (2004).
45. Wu, L. C., Ho, J. A., Shieh, M. C., and Lu, I. W., Antioxidant and antiproliferative activities of Spirulina and Chlorella water extracts. J. Agric. Food Chem., 53, 4207-4212 (2005).
46. Yasuda, M., Shimizu, I., Shiba, M., and Ito, S., Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology, 29, 719-727 (1999).